Keros Therapeutics names Charles Newton to board of directors

Go back to Keros Therapeutics names Charles Newton to board of directors
(NASDAQ: KROS) Delayed: 11.32 +0.21 (1.89%)
Previous Close $11.11    52 Week High
Open $11.03    52 Week Low
Day High $11.40    P/E N/A 
Day Low $11.02    EPS
Volume 65,638